MedTrace Logo

The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)

NCT00831662 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 490

Last updated 2015-01-09

No results posted yet for this study

Summary

The purpose of this study is to confirm the safety and efficacy of diquafosol tetrasodium ophthalmic solution, 2% vs. placebo, in subjects with dry eye disease.

Conditions

Interventions

DRUG

Diquafosol tetrasodium ophthalmic solution, 2%

One to two drops in each eye QID for 6 weeks

DRUG

Placebo

One to two drops in each eye QID for 6 weeks

Sponsors & Collaborators

Principal Investigators

  • Reza Haque, MD, PhD · Medical Monitor, Inspire

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-12-31
Completion
2009-12-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00831662 on ClinicalTrials.gov